|
R&D Systems
human fgf2 antibody ![]() Human Fgf2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human fgf2 antibody/product/R&D Systems Average 91 stars, based on 1 article reviews
human fgf2 antibody - by Bioz Stars,
2026-03
91/100 stars
|
Buy from Supplier |
|
R&D Systems
goat antibodies ![]() Goat Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/goat antibodies/product/R&D Systems Average 92 stars, based on 1 article reviews
goat antibodies - by Bioz Stars,
2026-03
92/100 stars
|
Buy from Supplier |
|
R&D Systems
biotinylated anti fgf2 antibody ![]() Biotinylated Anti Fgf2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/biotinylated anti fgf2 antibody/product/R&D Systems Average 90 stars, based on 1 article reviews
biotinylated anti fgf2 antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
R&D Systems
fgf 2 ![]() Fgf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/fgf 2/product/R&D Systems Average 93 stars, based on 1 article reviews
fgf 2 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
R&D Systems
anti bfgf β1 ![]() Anti Bfgf β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti bfgf β1/product/R&D Systems Average 94 stars, based on 1 article reviews
anti bfgf β1 - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
R&D Systems
cx3cl1 365 fr cytokines ![]() Cx3cl1 365 Fr Cytokines, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cx3cl1 365 fr cytokines/product/R&D Systems Average 90 stars, based on 1 article reviews
cx3cl1 365 fr cytokines - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
R&D Systems
polyclonal goat anti basic fibroblast growth factor fgf 2 antibody ![]() Polyclonal Goat Anti Basic Fibroblast Growth Factor Fgf 2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/polyclonal goat anti basic fibroblast growth factor fgf 2 antibody/product/R&D Systems Average 93 stars, based on 1 article reviews
polyclonal goat anti basic fibroblast growth factor fgf 2 antibody - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
ImmunoStar inc
polyclonal antibodies raised against human fgf2 ab773 ![]() Polyclonal Antibodies Raised Against Human Fgf2 Ab773, supplied by ImmunoStar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/polyclonal antibodies raised against human fgf2 ab773/product/ImmunoStar inc Average 90 stars, based on 1 article reviews
polyclonal antibodies raised against human fgf2 ab773 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Texas Biotechnology Inc
neutralizing monoclonal antibody to human fgf-2 mab 354fi ![]() Neutralizing Monoclonal Antibody To Human Fgf 2 Mab 354fi, supplied by Texas Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/neutralizing monoclonal antibody to human fgf-2 mab 354fi/product/Texas Biotechnology Inc Average 90 stars, based on 1 article reviews
neutralizing monoclonal antibody to human fgf-2 mab 354fi - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Ozyme Inc
anti-human hgf, fgf-2 and vegf antibodies ![]() Anti Human Hgf, Fgf 2 And Vegf Antibodies, supplied by Ozyme Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-human hgf, fgf-2 and vegf antibodies/product/Ozyme Inc Average 90 stars, based on 1 article reviews
anti-human hgf, fgf-2 and vegf antibodies - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
MBL Life science
rabbit anti-human fgf2 polyclonal antibody ![]() Rabbit Anti Human Fgf2 Polyclonal Antibody, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rabbit anti-human fgf2 polyclonal antibody/product/MBL Life science Average 90 stars, based on 1 article reviews
rabbit anti-human fgf2 polyclonal antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
OriGene
fgf2 (nm_002006) human recombinant protein ![]() Fgf2 (Nm 002006) Human Recombinant Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/fgf2 (nm_002006) human recombinant protein/product/OriGene Average 90 stars, based on 1 article reviews
fgf2 (nm_002006) human recombinant protein - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Cancer Prevention
Article Title: Nuclear Localization of Fibroblast Growth Factor Receptor 1 in Breast Cancer Cells Interacting with Cancer Associated Fibroblasts
doi: 10.15430/jcp.2022.27.1.68
Figure Lengend Snippet: Figure 1. Involvement of FGF2-FGFR1 axisin Akt activation. (A) The effect of CAF-CM on proliferation of breast cancer (MCF-7, MDA-MB-231, and MDA-MB-468) cells was determined by the MTT assay. Cells were incubated with or without CAF-CM for 72 hours. ***Significantly different be- tween the groups compared (P < 0.001). (B) MDA-MB-231 cells were incubated with CAF-CM for the indicated time periods. Phosphorylation of Akt and STAT3 were detected by Western blot analysis. (C) MDA-MB-231 cells were exposed to CAF-CM with or without FGF-2-neutralizing antibody for 3 hours. Phosphorylation of Akt was detected by Western blot analysis. *,***Significantly different between the groups compared (*P < 0.05; ***P < 0.001). (D) MDA-MB-231 cells were treated with 20 ng/mL of FGF2 for the indicated time periods. The phosphorylation of FRS2α as well as Akt was analyzed by Western blot. (E) RNA-seq data set of TCGA breast invasive carcinoma was downloaded from XenaBrower (https://xenabrowser.net). mRNA expression levels of total 1,097 samples (Illumina HiSeq log [normalized counts + 1]) were prepared by quantile normalization. Pearson cor- relation coefficient was calculated to assess the relationship between FGF2 and FGFR1. (F, G) Correlation of FGFR1 protein expression with FGF2 (F) and Akt (G), based on 105 breast invasive carcinoma protein specimens (TCGA, Pan-Cancer Atlas) from the cBioportal database (www.cbiopor- tal.org). FGF2, fibroblast growth factor 2; FGFR1, FGF receptor 1; CAFs, cancer-associated fibroblasts; NFs, normal fibroblasts; CM, conditioned medium; ns, not significantly different; FRS2, FGFR substrate 2; TCGA, The Cancer Genome Atlas; CPTAC, the Clinical Proteomic Tumor Analysis Consortium.
Article Snippet: For neutralization of FGF2 in the CM of CAFs, CM was pre-incubated with 25 μg/mL of
Techniques: Activation Assay, MTT Assay, Incubation, Phospho-proteomics, Western Blot, RNA Sequencing, Expressing
Journal: Journal of Cancer Prevention
Article Title: Nuclear Localization of Fibroblast Growth Factor Receptor 1 in Breast Cancer Cells Interacting with Cancer Associated Fibroblasts
doi: 10.15430/jcp.2022.27.1.68
Figure Lengend Snippet: Figure 2. Role of FGFR1 in Akt phosphorylation and breast cancer cell growth and progression. (A) MDA-MB-231 cells were transfected with scrambled or FGFR1 si-RNA for 24 hours. Cells were then incubated with 20 ng/mL of FGF2 for 15 minutes to measure phosphorylated FRS2α. (B) Mice were subjected to xenograft co-injecting with fibroblasts and MDA-MB-231 breast cancer cells. A complex collagen network was detected in H&E-stained tumors by an intense pink and in Masson’s trichrome stain by a blue stain (arrows). Stromal compartment was also detected by α-SMA immunostaining. Magnification, x100. Bars, 100 μm. (C) Phosphorylated Akt in the xenograft tumors was determined by Western blot analysis. *Sig- nificantly different between the groups compared (P < 0.05). (D) Enrichment plots of hallmark gene sets in the high FGFR1-expressing group. FGF2, fibroblast growth factor 2; FGFR1, FGF receptor 1; FRS2, FGFR substrate 2; α-SMA, alpha-smooth muscle actin; CONT, control; EMT, epithelial- mesenchymal transition.
Article Snippet: For neutralization of FGF2 in the CM of CAFs, CM was pre-incubated with 25 μg/mL of
Techniques: Phospho-proteomics, Transfection, Incubation, Staining, Immunostaining, Western Blot, Expressing, Control
Journal: Journal of Cancer Prevention
Article Title: Nuclear Localization of Fibroblast Growth Factor Receptor 1 in Breast Cancer Cells Interacting with Cancer Associated Fibroblasts
doi: 10.15430/jcp.2022.27.1.68
Figure Lengend Snippet: Figure 3. The involvement of FGF2-induced ROS generation in nuclear localization of FGFR1. (A) MDA-MB-231 cells were co-cultured with NFs or CAFs for 24 hours. MDA-MB-231 (5 x 10 3 cells) and NFs or CAFs (5 x 10 3 cells) were mixed prior to seeding and incubated for 24 hours. Immunocytochemical analysis was performed using anti-FGFR1 antibody. Cells were then stained with DAPI for detection of nuclei. Magnification, x100. Bars, 200 μm. (B) MDA-MB-231 cells were incubated with FGF2 for 1 hour. Immunocytochemical analysis was performed using anti-FGFR1 antibody. Cells were then stained with PI for detection of nuclei. Magnification, x100. Bars, 200 μm. (C) MDA-MB-231 cells were treated with 20 ng/ mL of FGF2 for 1 hour, followed by Western blot analysis of FGFR1 in cytosolic and nuclear extracts. Lamin B was used as a nuclear marker. *Sig- nificantly different between the groups compared (P < 0.05). (D, E) MDA-MD-231 cells were incubated with CAF-CM or FGF2 for 3 hours and 1 hour, respectively. After staining with DCF-DA for 30 minutes, fluorescent microscopic (D) or flow cytometric (E) analysis was performed to detect intracellu- lar ROS accumulation. Magnification, x40. (F) After pretreatment with NAC for 3 hours, cells were exposed to FGF2 for additional 1 hour. Nuclear ex- tracts were subjected to Western blot analysis to detect the presence of FGFR1 and Nrf2 in the nucleus. **Significantly different between the groups compared (P < 0.01). (G) MDA-MB-231 cells were exposed to FGF2 (20 ng/mL) for 1 hour. Cell lysates were subjected to immunoprecipitation using CBP antibody for 16 hours followed by immunoblotting with. FGFR1 or Nrf2 antibody. FGF2, fibroblast growth factor 2; FGFR1, FGF receptor 1; ROS, reactive oxygen species; CAFs, cancer-associated fibroblasts; CM, conditioned medium; NFs, normal fibroblasts; DAPI, 4′,6-diamidino-2-phenylindole; PI, propidium iodide; CONT, cotrol; DCF-DA, 2’,7’-dichlorodihydrofluorescein diacetate; NAC, N-acetylcysteine; CBP, CREB-binding protein.
Article Snippet: For neutralization of FGF2 in the CM of CAFs, CM was pre-incubated with 25 μg/mL of
Techniques: Cell Culture, Incubation, Staining, Western Blot, Marker, Immunoprecipitation, Binding Assay
Journal: Journal of Cancer Prevention
Article Title: Nuclear Localization of Fibroblast Growth Factor Receptor 1 in Breast Cancer Cells Interacting with Cancer Associated Fibroblasts
doi: 10.15430/jcp.2022.27.1.68
Figure Lengend Snippet: Figure 4. Possible association between nuclear FGFR1 and Nrf2. (A) TNBC patient cohorts were validated based on the mean expression value of the indicated single genes (FGFR1 or NFE2L2) or as a signature of two genes together and patient survival was analyzed (n = 255). (B, C) MDA- MB-231 cells were transfected with scrambled or Nrf2 si-RNA for 24 hours. Cells were then incubated with 20 ng/mL of FGF2 for 3 hours. The mRNA (B) and protein (C) expression of cyclin D1 was assessed by RT-PCR and Western blot analyses, respectively. The expression of cyclin D1 was mea- sured by RT-PCR (B) and Western blot (C) analyses. (D) In tumor microenvironment, fibroblasts are activated to form CAFs, which secrete FGF2. CAF-derived FGF2 could induces nuclear translocation as well as de novo synthesis of FGFR1, ultimately contributing to cancer cell proliferation, mi- gration and tumor growth. While membrane bound FGFR1 may translocate to nucleus as a complex with FGF2 which has nuclear localization signal (NLS), the complex is likely rather to stimulate the intracellular signaling via FRS2α, which induces transcription of FGFR-1 gene. On the other hand, newly synthesized FGFR-1 is speculated to enter the nucleus as a complex with a cargo protein harboring NLS. FGFR-1 is translocated to the inner nuclear membrane through the nuclear pore complexes (NPCs), which is regulated by importin β. FGF2, fibroblast growth factor 2; FGFR1, FGF receptor 1; TNBC, triple negative breast cancer; HR, hazard ratio; CAFs, cancer-associated fibroblasts; ER, endoplasmic reticulum; FRS2, FGFR substrate 2; CBP, CREB-binding protein.
Article Snippet: For neutralization of FGF2 in the CM of CAFs, CM was pre-incubated with 25 μg/mL of
Techniques: Expressing, Transfection, Incubation, Reverse Transcription Polymerase Chain Reaction, Western Blot, Derivative Assay, Translocation Assay, Membrane, Synthesized, Binding Assay
Journal: Cerebrospinal Fluid Research
Article Title: Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain
doi: 10.1186/1743-8454-7-13
Figure Lengend Snippet: Altered distribution of FGF2 in the rat neurohypophysis after dehydration: In normal (A & B) and water-deprived rats (C & D), tissues were immunostained with polyclonal antibodies against FGF2: To visualize the changes in the localization of FGF2 in the extracellular matrix, tissue sections were treated with antibody Ab773 (A & C). To visualize the changes in intracellular FGF2, tissue sections were treated with antibody Ab106 (B & D). In control animals, FGF2 is associated with basement membranes (arrowheads), Herring bodies of axons of neurosecretory neurons (stars) (A) and pituicytes (arrows). Notice the characteristic beaded appearance of axons (B). In neurohypophyseal tissue from experimental rats, (C) and (D) show that the characteristic morphological changes associated with chronic dehydration are accompanied by increased FGF2 staining in structures underlying the perivascular space (arrowheads) (C). The hypertrophic pituicytes (arrows) also display strong nuclear staining (D). (Magnification bar = 100 μm)
Article Snippet: Immunohistochemical procedures used specific
Techniques: Control, Staining
Journal: Cerebrospinal Fluid Research
Article Title: Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain
doi: 10.1186/1743-8454-7-13
Figure Lengend Snippet: Altered distribution of FGF2 in choroid plexus of rat brain after dehydration: FGF2 immunostaining in lateral ventricle choroid plexus tissues was evaluated in adult rats exposed to chronic water deprivation for 72 h. Anatomically, the choroidal villus consists of a single layer of cuboidal epithelial cells that circumferentially surrounds an inner vascular core and extracellular matrix. The apical membrane faces the 'outside' CSF compartment; see Smith et al. for a delineated description of choroid structural features. Note the marked FGF2 immunostaining in plexus parenchymal epithelium from a dehydrated animal (A), particularly in the nuclei, cytoplasm and the apical (CSF-facing) membrane, and the lower concentration in basement membranes (B). Comparatively, normal animals show lower levels of intracellular FGF2 in the epithelium (C), but stronger staining associated with basement membranes (D). Tissues were immunostained with polyclonal antibodies against FGF2: Ab106 (A & C) and Ab773 (B & D).
Article Snippet: Immunohistochemical procedures used specific
Techniques: Immunostaining, Membrane, Concentration Assay, Staining
Journal: Cerebrospinal Fluid Research
Article Title: Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain
doi: 10.1186/1743-8454-7-13
Figure Lengend Snippet: Immunoblotting confirms enhanced hypothalamic FGF2 expression after dehydration: FGF2 protein level was analyzed by western blotting for control (C) and dehydrated (D) states. Note the increased FGF2 levels in hypothalamus, resulting from 3 days of water deprivation, for the 3 isoforms of about 18, 23 and 24 kDa. Heart, kidney and brain rat tissues were extracted as described in the text and examined for rat FGF2 with a polyclonal antibody recognizing 3 forms of endogenous FGF2. Equal amounts of protein were loaded per well. Exposure time was 36 h. Dehydration specifically elevated the expression of FGF2 in hypothalamus but not in heart or kidney.
Article Snippet: Immunohistochemical procedures used specific
Techniques: Western Blot, Expressing, Control